rs137852803
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The ENST00000348749.9(CHRNA1):c.805G>T(p.Val269Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V269L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000348749.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA1 | NM_000079.4 | c.805G>T | p.Val269Phe | missense_variant | 7/9 | ENST00000348749.9 | NP_000070.1 | |
CHRNA1 | NM_001039523.3 | c.880G>T | p.Val294Phe | missense_variant | 8/10 | NP_001034612.1 | ||
CHRNA1 | XM_017003256.2 | c.901G>T | p.Val301Phe | missense_variant | 7/9 | XP_016858745.1 | ||
CHRNA1 | XM_017003257.2 | c.826G>T | p.Val276Phe | missense_variant | 6/8 | XP_016858746.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNA1 | ENST00000348749.9 | c.805G>T | p.Val269Phe | missense_variant | 7/9 | 1 | NM_000079.4 | ENSP00000261008 | P1 | |
ENST00000442996.1 | n.321+20319C>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2017 | - - |
Congenital myasthenic syndrome 1A Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 1997 | - - |
Lethal multiple pterygium syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 07, 2021 | ClinVar contains an entry for this variant (Variation ID: 18381). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with phenylalanine at codon 269 of the CHRNA1 protein (p.Val269Phe). The valine residue is highly conserved and there is a small physicochemical difference between valine and phenylalanine. This variant has been observed in individual(s) with congenital myasthenia (PMID: 9221765). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CHRNA1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this variant affects CHRNA1 protein function (PMID: 9221765). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at